A Study of MEK162 in NRAS mutated metastatic melanoma patients with brain metastases - Brain-MEK-Study
Latest Information Update: 28 May 2019
At a glance
- Drugs Binimetinib (Primary)
- Indications Brain metastases; Malignant melanoma
- Focus Adverse reactions
- Acronyms Brain-MEK-Study
- 15 Sep 2016 New trial record